Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study.


Journal

Drug metabolism reviews
ISSN: 1097-9883
Titre abrégé: Drug Metab Rev
Pays: England
ID NLM: 0322067

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 12 2 2019
medline: 31 12 2019
entrez: 12 2 2019
Statut: ppublish

Résumé

In this Review article, recent progress in matter of graphene oxide (GO) synthesis and its functionalization via a vast range of materials, including small molecules, polymers, and biomolecules, were reported and systematically summarized in order to overcome the inherent drawbacks of GO nanocarriers and thereby make these nanocarriers suitable for delivering chemotherapeutic agents, genes, and short interfering RNAs. Briefly, this work describes current strategies for the large scale production of GO and modification of graphene-based nanocarriers surfaces through practical chemical approaches, improving their biocompatibility and declining their toxicity. It also describes the most relevant cases of study suitable to demonstrate the role of graphene and graphene derivatives (GD) as nanocarrier for anti-cancer drugs and genes (e.g. miRNAs). Moreover, the controlled release mechanisms within the cell compartments and blood pH for targeted therapeutics release in the acidic environment of tumor cells or in intracellular compartments are mentioned and explored.

Identifiants

pubmed: 30741033
doi: 10.1080/03602532.2018.1522328
doi:

Substances chimiques

Antineoplastic Agents 0
Drug Carriers 0
graphene oxide 0
Graphite 7782-42-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-41

Auteurs

Seyyed Mojtaba Mousavi (SM)

a Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies , Shiraz University of Medical Sciences , Shiraz , Iran.
b Pharmaceutical Sciences Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.

Seyyed Alireza Hashemi (SA)

a Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies , Shiraz University of Medical Sciences , Shiraz , Iran.
b Pharmaceutical Sciences Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.

Younes Ghasemi (Y)

a Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies , Shiraz University of Medical Sciences , Shiraz , Iran.
b Pharmaceutical Sciences Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.

Ali Mohammad Amani (AM)

a Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies , Shiraz University of Medical Sciences , Shiraz , Iran.
b Pharmaceutical Sciences Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.

Aziz Babapoor (A)

b Pharmaceutical Sciences Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.
c Department of Chemical Engineering , University of Mohaghegh Ardabili (UMA) , Ardabil , Iran.

Omid Arjmand (O)

d Department of Chemical Engineering, South Tehran Branch , Islamic Azad University , Tehran , Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH